Facing challenges with hope: universal immune cells for hematologic malignancies

Many patients have achieved a favorable overall survival rate since allogenic hematopoietic stem cell transplantation (allo-HSCT) has been widely implemented to treat hematologic malignancies. However, graft-versus-host disease (GVHD) and complications of immunosuppressive drugs after allo-HSCT are...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuqing, Huang, Ruihao, Wang, Zheng, Xiong, Jingkang, Wang, Xiaoqi, Zhang, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157807/
https://www.ncbi.nlm.nih.gov/pubmed/37144558
http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157807/
https://www.ncbi.nlm.nih.gov/pubmed/37144558
http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0759

Ejemplares similares